Impressive, but also -- in retrospect -- kind of obvious. Why, of course you want to target destructive chemotherapy directly to tumors, via precise physical delivery.

I wonder if outdated assumptions about the limits of manufacturing prevented doctors/researchers/incumbent-companies from more actively pursuing this idea. It may take an outsider on a mission to remind a field of what's possible.